Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
K. Buesch
ResearcherPublications, citations & collaboration network
K. Buesch is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 86 works, 471 citations, an h-index of 10 and an i10-index of 11.
86
Works
471
Citations
10
h-index
11
i10-index
IDs:OpenAlex
How has K. Buesch's publication output changed over time?
ScholarIQpublication output · 2006–2022
Output grew300% over the shown period — from 1 works in 2006 to 4 in 2022.
1
1
4
4
2006201120212022
What are the most-cited papers on K. Buesch?
ScholarIQmost cited works
Mortality, morbidity and costs attributable to smoking in Germany: update and a 10-year comparison
Simone Neubauer, R Welte, Alexandra Beiche, Hans-Helmut Koenig, K. Buesch, Reiner Leidl
Tobacco Control. 2006163 CitationsOPEN ACCESS
Prognostic indicators of disease progression in Duchenne muscular dystrophy: A literature review and evidence synthesis
Nermina Ferizović, Jessica J. Summers, Igor Beitia Ortiz de Zárate, Christian Werner, Joel Jiang, Erik Landfeldt, K. Buesch
PLoS ONE. 202226 CitationsOPEN ACCESS
A systematic review of disease prevalence, health-related quality of life, and economic outcomes associated with Friedreich’s Ataxia
K. Buesch, Rongrong Zhang
Current Medical Research and Opinion. 202223 CitationsOPEN ACCESS
Cost‐effectiveness analysis of palivizumab as respiratory syncytial virus prophylaxis in preterm infants in Sweden
Kristian Neovius, K. Buesch, Kristina Sandström, Martin Neovius
Acta Paediatrica. 201122 CitationsOPEN ACCESS
Cost of Illness in Patients with Duchenne Muscular Dystrophy in Portugal: The COIDUCH Study
Pedro Labisa, V. Andreozzi, Melina Mota, Susana Monteiro, Rita Alves, João Paulo Felix Augusto de Almeida, Björn Vandewalle, Jorge Felix, K. Buesch, Hugo Canhão, Igor Beitia Ortiz de Zárate
PharmacoEconomics - Open. 202121 CitationsOPEN ACCESS
Related on ScholarIQ
Novartis (Switzerland)
Institution
Mortality, morbidity and costs attributable to smoking in Germany: update and a 10-year comparison
Paper
Prognostic indicators of disease progression in Duchenne muscular dystrophy: A literature review and evidence synthesis
Paper
A systematic review of disease prevalence, health-related quality of life, and economic outcomes associated with Friedreich’s Ataxia
Paper
Cost‐effectiveness analysis of palivizumab as respiratory syncytial virus prophylaxis in preterm infants in Sweden
Paper
Cost of Illness in Patients with Duchenne Muscular Dystrophy in Portugal: The COIDUCH Study
Paper